<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39127990</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2193-8229</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Infectious diseases and therapy</Title><ISOAbbreviation>Infect Dis Ther</ISOAbbreviation></Journal><ArticleTitle>A Practical Approach to Tailor the Term Long COVID for Diagnostics, Therapy and Epidemiological Research for Improved Long COVID Patient Care.</ArticleTitle><Pagination><StartPage>1921</StartPage><EndPage>1928</EndPage><MedlinePgn>1921-1928</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40121-024-01025-x</ELocationID><Abstract><AbstractText>The term long COVID (LC) effectively describes the broad long-term disease burden of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infections, encompassing individual suffering and significant socioeconomic impacts. However, its general use hampers precise epidemiological research, diagnostics and therapeutic strategies. Misinterpretations occur, for example, when population surveys are compared to studies using health record data, because both refer to these data as LC. This also emphasizes the need for different terminology. The National Institute for Health and Care Excellence (NICE) rapid guideline differentiates ongoing symptomatic COVID-19 from post-COVID conditions, yet real-world observations challenge these two subgroup definitions. We propose refining the term LC into three subgroups: ongoing symptomatic COVID-19, SARS-CoV-2 induced or exacerbated diseases and post-acute COVID condition. This stratification aids targeted diagnostics, treatment and epidemiological research. Subgroup-specific documentation using the International Classification of Diseases, Tenth Revision (ICD-10) codes ensures accurate tracking and understanding of long-term effects. The subgroup of post-acute COVID condition again includes various symptoms, syndromes and diseases like post-exertional malaise (PEM), dysautonomia or cognitive dysfunctions. In this regard, differentiation, especially considering PEM, is crucial for effective diagnostics and treatment.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8760-4250</Identifier><AffiliationInfo><Affiliation>Department of Primary Care Medicine, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15/I, 1090, Vienna, Austria. Kathryn.hoffmann@meduniwien.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stingl</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Facharztzentrum Votivpark, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Mahony</LastName><ForeName>Liam</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Departments of Medicine and Microbiology, APC Microbiome Ireland, National University of Ireland, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Untersmayr</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute for Pathophysiology und Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Infect Dis Ther</MedlineTA><NlmUniqueID>101634499</NlmUniqueID><ISSNLinking>2193-6382</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical coding</Keyword><Keyword MajorTopicYN="N">Definition</Keyword><Keyword MajorTopicYN="N">Diagnostics</Keyword><Keyword MajorTopicYN="N">Epidemiological research</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword></KeywordList><CoiStatement>Kathryn Hoffmann, Michael Stingl, Liam O'Mahony, and Eva Untersmayr declare they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>11</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>11</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>11</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39127990</ArticleId><ArticleId IdType="pmc">PMC11343936</ArticleId><ArticleId IdType="doi">10.1007/s40121-024-01025-x</ArticleId><ArticleId IdType="pii">10.1007/s40121-024-01025-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46. 10.1038/s41579-022-00846-2. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect Dis. 2023;23:393&#x2013;5. 10.1016/S1473-3099(23)00053-1. 10.1016/S1473-3099(23)00053-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). A clinical case definition of post COVID-19 condition by a Delphi consensus (2021).</Citation></Reference><Reference><Citation>National Academies of Sciences, Engineering &amp; Medicine. Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection. (2024). https://nap.nationalacademies.org/catalog/27756/long-term-health-effects-of-covid-19-disability-and-function</Citation></Reference><Reference><Citation>Ewing AG, et al. Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology. Med Rev. 2024;2:2.</Citation></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Postacute sequelae of SARS-CoV-2 infection in the pre-delta, delta, and omicron eras. N Engl J Med. 2024. 10.1056/NEJMoa2403211. 10.1056/NEJMoa2403211</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2403211</ArticleId><ArticleId IdType="pubmed">39018527</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. 2022;28:955&#x2013;72. 10.1016/j.cmi.2022.02.018. 10.1016/j.cmi.2022.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, et al. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: a consensus statement and scoping review from the global COVID-19 neuro research coalition. J Neurol Sci. 2023;120:827.</Citation><ArticleIdList><ArticleId IdType="pubmed">37856998</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;64. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra AR, et al. The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob Stewardship Healthc Epidemiol. 2023;3: e168. 10.1017/ash.2023.447.10.1017/ash.2023.447</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ash.2023.447</ArticleId><ArticleId IdType="pmc">PMC10644173</ArticleId><ArticleId IdType="pubmed">38028898</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28:1461&#x2013;7. 10.1038/s41591-022-01840-0. 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28:2398&#x2013;405. 10.1038/s41591-022-02051-3. 10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M, Xie Y, Topol EJ, Al-Aly Z. Three-year outcomes of post-acute sequelae of COVID-19. Nat Med. 2024;30:1564&#x2013;73. 10.1038/s41591-024-02987-8. 10.1038/s41591-024-02987-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-02987-8</ArticleId><ArticleId IdType="pmc">PMC11186764</ArticleId><ArticleId IdType="pubmed">38816608</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28:911&#x2013;23. 10.1038/s41591-022-01810-6. 10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrhofer J, et al. Immunological patient stratification in myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Med. 2024;13:275. 10.3390/jcm13010275</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13010275</ArticleId><ArticleId IdType="pmc">PMC10779792</ArticleId><ArticleId IdType="pubmed">38202282</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva J, et al. Sex differences in symptomatology and immune profiles of long COVID. MedRxiv. 2024. 10.1101/2024.02.29.24303568. 10.1101/2024.02.29.24303568</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.02.29.24303568</ArticleId><ArticleId IdType="pmc">PMC11326360</ArticleId><ArticleId IdType="pubmed">39148819</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B, et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun. 2024;15:17. 10.1038/s41467-023-44432-3. 10.1038/s41467-023-44432-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="pubmed">38177128</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H, Scheibenbogen C. Post-COVID-Syndrom mit Fatigue und Belastungsintoleranz: Myalgische Enzephalomyelitis bzw. Chronisches Fatigue-Syndrom. Die Innere Medizin. 2022;63:830&#x2013;9. 10.1007/s00108-022-01369-x. 10.1007/s00108-022-01369-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00108-022-01369-x</ArticleId><ArticleId IdType="pmc">PMC9281337</ArticleId><ArticleId IdType="pubmed">35925074</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM&amp;R. 2022;14:1270&#x2013;91. 10.1002/pmrj.12894</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12894</ArticleId><ArticleId IdType="pmc">PMC9538426</ArticleId><ArticleId IdType="pubmed">36169154</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Topol E. Solving the puzzle of long covid. Science. 2024;383:830&#x2013;2. 10.1126/science.adl0867. 10.1126/science.adl0867</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adl0867</ArticleId><ArticleId IdType="pubmed">38386747</ArticleId></ArticleIdList></Reference><Reference><Citation>
Statistics Canada (2023). https://www150.statcan.gc.ca/n1/daily-quotidien/231208/dq231208a-eng.htm</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>